Trial reportBMC pulmonary medicine2025
Evaluation of patients diagnosed with chronic obstructive pulmonary disease in terms of treatment compliance and quality of life after follow-up with telemedicine: a randomized controlled trial.
Trial report in BMC pulmonary medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06477328 (Treatment Compliance of Patients Diagnosed With Chronic Obstructive Pulmonary Disease And Their Quality of Life After Follow-up), which is not on this map. Cited by 4 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Treatment Compliance of Patients Diagnosed With Chronic Obstructive Pulmonary Disease And Their Quality of Life After Follow-up: Evaluation Via Telemedicine
Who cites it
4 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Comparative efficacy of digital health interventions and traditional mind-body exercises for pulmonary rehabilitation in chronic obstructive pulmonary disease: a systematic review and network meta-analysis.Frontiers in medicine · 2026Pooled it
- Mortality trends and disparities in older U.S. adults with atrial fibrillation and COPD: a 1999-2020 CDC WONDER analysis with forecast to 2030.Frontiers in cardiovascular medicine · 2026Article
- Interventions Evaluated to Improve Inhaler Adherence in Patients with Chronic Obstructive Pulmonary Disease: A Scoping Review.International journal of chronic obstructive pulmonary disease · 2026Article
- Artificial Intelligence-Based Interventions in Pulmonology: What Factors Influence Patient Participation in This Type of Study?Open respiratory archivesArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDuring the COVID-19 pandemic, telemedicine has emerged as an important alternative method. The investigation of the safety and effectiveness of telemedicine in the post-exacerbation follow-up of advanced-stage COPD patients and determining whether telemedicine-mediated healthcare service resulted in any differences in COPD assessment test (CAT) scores, inhaler treatment adherence, and technique compared to the face-to-face healthcare service.
methodsThis was a prospective, randomized, controlled, method-based clinical research study. Patients who were hospitalized due to COPD exacerbation were included in the present study. The sealed envelope randomization method was adopted to divide these patients into 2 groups: the "telemedicine group" and the "control group". Both groups were then followed up for 3 months. The 0th visit was considered the initial visit, which was followed by the 1st visit on Day 10 post-initiation, the 2nd visit at 1 month, and the 3rd visit at 3 months, all assessed via teleconsultations. The COPD assessment questionnaire (CAT) scores, inhaler treatment adherence, and technique were compared between the groups.
resultsNo significant differences existed between the two groups in terms of demographic data and disease characteristics at baseline assessment. At the end of 3 months, the CAT score was 9 (0-30) in the telemedicine group and 18 (0-34) in the control group (p = 0.019). The inhaler treatment technique was correct in 32 patients (91.4%) in the telemedicine group and 23 patients (65.7%) in the control group (p = 0.02). Inhaler treatment adherence was observed in 70.6% of the patients in the telemedicine group and 55.9% of the patients in the control group at the 3-month time point (p > 0.05).
conclusionsTelemedicine has improved the quality of life of advanced-stage COPD patients and their inhaler techniques. It may, therefore, be considered a promising alternative to traditional face-to-face follow-ups, although various technical infrastructures and legal regulations are necessary.
trial registrationClinicalTrials.gov ID: NCT06477328, Registration Date: 21.06.2024.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.